Navigation Links
SmartCycler 1600 System

ProductsSmartCycler 1600 System
Company Cepheid
Item SmartCycler 1600 System
Features 
Description The SmartCycler System is a rapid, real-time thermal cycler used for identifying DNA/RNA from prepared biological samples. By automating much of the testing process, and making each reaction site individually programmable, it is the fastest, easiest to use, and most flexible system now on the market. The SmartCycler delivers highly accurate and consistent test results in as little as 20 minutes.

Flexible
With up to 96 independently programmable reaction sites, the SmartCycler can simultaneously run multiple experiments with different protocols and at different times. This enables multiple users to use SmartCycler simultaneously. This eliminates complex advanced scheduling on larger, more costly systems as well as the need to transport samples to central facilities for analysis.

Fast
There's no need to wait hours or days for results on other platforms. With capability to perform extremely rapid heating and cooling cycles, the SmartCycler System can deliver results in as little as 20 minutes.

Real-time detection
Each independently programmable module performs four-color, real-time fluorometric detection. Samples are amplified and measured in the SmartCycler's proprietary, sealable reaction tubes that are designed to optimize rapid thermal transfer and optical sensitivity, as well as to reduce the possibility of amplicon contamination.

Four-channel optics
The SmartCycler System enables the detection of several targets within a single sample (multiplex assays) by using multiple fluorescent dyes and detecting the fluorescent signal in four channels. The instrument's optics allow application to the rapidly evolving needs of a molecular biology lab using detection methods including Molecular Beacons and TaqMan probes, Amplifluor and Scorpion primers, and intercalating dyes such as SYBR Green.

Expandable
Users can configure a system to suit their exact needs - with 16, 32, 48, 64, 80 or 96 reaction sites. As testing volumes expand, more sites can be added to a system at any time. The system software enables one or more operators to define and simultaneously carry out separate experiments, each with a unique set of cycling protocols, threshold criteria, and data analysis. Additionally, thermal and optical data can be monitored in real-time, and graphs of temperature, growth, and melt curves are displayed during data collection.

Info Cepheid
Customer Service: (408) 541-4191
Web site: http://www.cepheid.com/

Related medicine products :

1. SmartCycler® 6400 System
2. SmartCycler 4800 System
3. SmartCycler® 3200 System
4. SmartCycler 3200 System
5. SmartCycler 6400 System
6. SmartCycler 9600 System
7. SmartCycler® 8000 System
8. SmartCycler 8000 System
9. Silicone Oil Cannula System - 20 Gauge
10. Silicone Oil Cannula System - 19 Gauge
11. SuperVu Galilean System
Breaking Medicine News(10 mins):Health News:Controversial kidney transplant technique could provide lifeline for very ill patients 2Health News:BridgeGate International Announces New Integration and Interoperability Training Program 2Health News:BridgeGate International Announces New Integration and Interoperability Training Program 3Health News:BridgeGate International Announces New Integration and Interoperability Training Program 4Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 2Health News:Concord Coalition Report Shows Eagerness for Reform, Readiness to Make Tough Choices on Fiscal Priorities 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4